Alphamab Oncology (HKG:9966)

Alphamab Oncology Revenue

In the year 2025, Alphamab Oncology had annual revenue of 566.24M CNY, down -11.54%. Alphamab Oncology had revenue of 246.80M in the half year ending December 31, 2025, with 199.84% growth.

• Revenue: 566.24M CNY
• Revenue Growth: -11.54%
• P/S Ratio: 18.43
• Revenue / Employee: 1.14M CNY
• Employees: 498
• Market Cap: 11.61B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	566.24M	-73.85M	-11.54%
Dec 31, 2024	640.08M	421.31M	192.58%
Dec 31, 2023	218.77M	51.93M	31.12%
Dec 31, 2022	166.85M	20.82M	14.26%
Dec 31, 2021	146.02M	-	-